Status:

COMPLETED

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

Lead Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions:

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Salivary Gland Squamous Cell Carcinoma

Eligibility:

All Genders

18+ years

Brief Summary

This pilot research trial studies circulating tumor deoxyribonucleic acid (DNA) in predicting outcomes in patients with stage IV head and neck cancer or stage III-IV non-small cell lung cancer. Studyi...

Detailed Description

PRIMARY OBJECTIVES: I. To evaluate the predictive value of the circulating tumor DNA for disease-free survival/progression-free survival in patients with advanced head and neck carcinoma (HNC) and no...

Eligibility Criteria

Inclusion

  • Patients older than 18 years age
  • Diagnosis of advanced HNC (Stage III, IVA, IVB, IVC) or NSCLC (Stage IIA, IIB, IIIA, IIIB, IV) (patients with synchronous advanced HNC and NSCLC are eligible)
  • ECOG performance status score of 0-3
  • Life expectancy of 3 months or longer
  • Patients able to provide a written informed consent prior to study entry

Exclusion

  • Prior chemotherapy or full course of radiotherapy for their present advanced HNC or NSCLC
  • Patients are excluded if they have a history of any other malignancy from which the patient has been disease-free for less than 2 years, with the exception of adequately treated basal or squamous cell carcinoma of skin
  • Other severe acute or chronic medical or psychiatric condition that may increase the risk associated with study participation, and in the judgment of the investigator would make the subject inappropriate for entry into this study

Key Trial Info

Start Date :

July 22 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 8 2023

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT02245100

Start Date

July 22 2014

End Date

December 8 2023

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107